Here, we describe the appearance and pattern of pulmonary lymphoma on B-mode imaging and with contrast-enhanced ultrasound (CEUS). From July 2009 to December 2015, 6 patients with histologically or cytologically confirmed lymphoma of the lung were examined by B-mode imaging, followed by CEUS. A retrospective analysis of the imaging data was performed with respect to the time to enhancement, pulmonary artery (PA) and bronchial artery, echogenicity (hypoechoic, isoechoic, or hyperechoic), and homogeneity (homogeneous or inhomogeneous) of the contrast enhancement. On B-mode imaging, all 6 pulmonary lymphoma lesions were hypoechoic. Five cases had PA enhancement, and 1 case had bronchial artery enhancement on CEUS imaging. Strikingly, all 6 patients had isoechoic arterial contrast enhancement. In the parenchymal phase, 3 of the lymphoma lesions showed hypoechoic contrast enhancement, and 3 showed isoechoic enhancement. Pulmonary lymphomas are hypoechoic on B-mode imaging. With CEUS, all patients had predominant PA contrast enhancement in the arterial phase with variable parenchymal contrast enhancement. Thus, definite differentiation from other malignant or benign pulmonary lesions cannot be achieved by CEUS.
By measuring the time to enhancement, one can differentiate between PA and BA vascularization. Furthermore, the evaluation of the extent of enhancement in the arterial and parenchymal phases enables further characterization of lung lesions. [8] [9] [10] [11] To the best of our knowledge, CEUS patterns of histologically confirmed lung lymphomas have not been reported in the literature. Here, we characterize 6 cases of pulmonary lymphomas by B-mode imaging and CEUS for the first time.
Patients, Materials, and Methods

Patients
From July 2009 to December 2015, 6 patients with histologically or cytologically confirmed lymphoma of the lung were examined by B-mode imaging and CEUS. In all patients, computed tomography (CT) was performed. On CT, the pulmonary lymphoma presented as an unknown mass and as alveolar or interstitial infiltrates. The study was approved by the Ethics Committee of the University Hospital and Philipps University in Marburg.
Ultrasound Procedures
Before CEUS, all patients were examined by B-mode imaging. The following B-mode data were evaluated retrospectively: echogenicity (hypoechoic or hyperechoic), homogeneity (homogeneous or inhomogeneous), and size of the lesion.
Contrast-enhanced US examinations were performed with an Acuson Sequoia GI US machine (Siemens AG, Erlangen, Germany), which has contrastspecific software with a low mechanical index. The CEUS examinations were conducted in accordance with European Federation of Societies for Ultrasound in Medicine and Biology guidelines. 8 Patients received an intravenous bolus of 2.4 mL of a second-generation sulfur hexafluoride microbubble contrast medium (SonoVue; Bracco SpA, Milan, Italy), followed by a bolus of 5 mL of sodium chloride, 0.9%. The pulmonary parenchymal lesions detected on grayscale imaging were continuously observed over 3 to 5 minutes during the CEUS examination. Video clips of CEUS were recorded. Subsequently, CEUS images from the clips were analyzed regarding the presence or absence of contrast enhancement.
After the contrast medium application, the time to enhancement in the lung was recorded to determine the vascularization type: PA vascularization was defined as contrast enhancement of the lesion before the detection of contrast media in the chest wall as an "in vivo" reference; and BA vascularization was defined 
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as simultaneous accumulation of contrast media in the pulmonary lesions and reference organs. The differentiation between hypoenhancement, isoenhancement, and hyperenhancement in the arterial (<1 minute) and parenchymal (>1 minute) phases was determined by comparing the lesion to the enhancement of the liver or spleen (extent of enhancement) and homogeneity of the enhancement.
Results
Five of the 6 patients were male. The average age was 75 years. Five of the pulmonary lymphomas were indolent, and 1 patient had an aggressive non-Hodgkin lymphoma. Primary extranodal involvement of the lung was observed in 3 cases, whereas in 3 cases, a secondary lymphoma manifestation of the lung was diagnosed. In 4 patients, cough was reported; 1 patient had fever with temperatures higher than 38 8C; and 1 patient had dyspnea.
On B-mode-imaging, all pulmonary lymphoma lesions were hypoechoic. The lesions measured 6 3 4 cm in 2 cases, 5 3 2 cm in 1 case, 4 3 2 cm in 1 case, and 2 3 1 cm in 2 cases. Pulmonary artery enhancement was observed in 5 cases (83%) and BA enhancement in 1 case (17 %). In the arterial phase, all pulmonary lesions (n 5 6) showed isoechoic contrast enhancement. In the parenchymal phase, 3 cases showed hypoechoic contrast enhancement, and 3 cases showed isoechoic enhancement. The contrast enhancement was inhomogeneous in 2 of the pulmonary lesions and homogeneous in 4 ( Figure 1 ). Figure 2 shows the corresponding CT of the case presented in Figure 1 . Figure 3 shows the corresponding hematoxylin-eosin staining.
Discussion
In general, the lung is suitable for the application of CEUS because of the dual blood supply system via the PA and BA. However, the method is limited to peripheral pulmonary or pleural lesions because of a strong reflection from the air of the alveoli and pulmonary tissue of the healthy lung. [8] [9] [10] [11] Therefore, alternative imaging techniques such as chest radiography and CT are often used for imaging studies of the lung and may explain the lack of sufficiently powered CEUS studies. However, over the past years, lung US in general and lung CEUS in particular have emerged as attractive and sensitive tools in experienced hands. 1, 2, [12] [13] [14] [15] Differentiation of benign and malignant peripheral lung lesions by CEUS is desirable but often not possible. However, in many cases, CEUS might help to classify peripheral lung lesions to be likely malignant versus likely benign. As always in US, a careful medical history often helps in the diagnostic workup and interpretation of imaging findings. In a recent study about the characteristics of peripheral pulmonary lesions, malignant lesions showed inhomogeneous enhancement and missing PA vascularization as well as rapid elimination of the contrast media in the parenchymal phase. 11 Our group recently reported CEUS patterns in patients with peripheral lung lesions and clinical and radiologic evidence of pulmonary embolism. 1 In this study, we defined absent or inhomogeneous PA enhancement as a typical pattern for suspected embolic lesions. Benign processes such as pneumonia, atelectasis, and infectious pleurisy are characterized by an PA and homogeneous enhancement with a slow elimination of the contrast media in the late phase. 11, 16 A few other studies about the type of vascularization of peripheral pulmonary lesions on CEUS showed similar results. [8] [9] [10] 17 However, a meaningful comparison of the studies is difficult because of the different methods and heterogeneous patient populations. In this series, pulmonary lymphomas surprisingly showed a PA vascularization pattern in all but 1 case, which is not typical for malignant lesions of the lung and, to our knowledge, has not been described before.
Inflammatory processes of the lungs are characterized by a rapid influx of contrast media with homogeneous enhancement in both contrast medium phases. 10, 18 With regard to the extent of contrast enhancement, isoechoic enhancement was observed in all pulmonary lymphomas and was also reported in patients with pneumonia. 10, 18 The enhancement in the parenchymal phase was variable, with parenchymal isoechoic and hypoechoic enhancement. Thus, the typical "wash-out" sign that has been understood to be a sign of malignancy was detected in 3 patients, whereas 3 patients also showed isoechoic parenchymal enhancement, which is also observed in CEUS patterns of pneumonia and atelectasis. The reason for this rather unexpected enhancement pattern remains unclear. One feasible hypothesis might be the pronounced inflammatory environment in lung lymphoma, which could be shown in our histologic examination. Recent data suggest that effective differentiation between malignant and inflammatory processes of the lung could be very challenging. 5, 19 In summary, our small pilot study of pulmonary lymphomas revealed an unexpected CEUS pattern of homogeneous PA enhancement in the arterial phase, followed by variable parenchymal contrast enhancement. Therefore, great care must be taken not to misdiagnose pulmonary lymphoma as atelectasis, pneumonia, or infectious pleurisy, in which similar CEUS patterns have been described.
